Class III · Low risk
Trandolapril and Verapamil Hydrochloride Extended-Release Tablets 2 mg / 180 mg
Subpotent: Out of Specification for Assay Test at the 3-month time point.
National Drug Code
Is NDC 68462-0295-01 recalled?
Trandolapril and Verapamil Hydrochloride · 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-295-01)
Yes — this exact package was recalled
1 FDA recall names the code 68462-0295-01 directly. A recall still applies to particular lot numbers — compare the lot on your package with the FDA notice below, and talk to your pharmacist before stopping a prescribed medication.
1 of these recalls is still ongoing.
- Active ingredient
- Trandolapril and Verapamil Hydrochloride
- Strength
- TRANDOLAPRIL 2 mg/1; VERAPAMIL HYDROCHLORIDE 180 mg/1
- Form
- Tablet, Film Coated, Extended Release · Oral
- Labeler
- Glenmark Pharmaceuticals Inc., USA
- Type
- Human Prescription Drug
- Product code
- 68462-0295
Recalls naming this package
Where to find this code. The NDC is printed on the pharmacy label and on the manufacturer's carton, usually as three groups of digits after “NDC”. The last group is the package size — two bottles of the same medicine can differ only in that group, and a recall may cover one but not the other.
Other recalled products from this labeler
- 68462-0164 Carvedilol 5
- 68462-0165 Carvedilol 4
- 68462-0248 See recall 4
- 68462-0357 Potassium Chloride 4
- 68462-0562 Diltiazem Hydrochloride 4
- 68462-0249 See recall 3
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.